Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
As the world’s population of older people rapidly grows in the coming years, Alzheimer’s and other forms of dementia will become a health-care disaster.
A recently approved plaque-tracking dye can improve doctors’ ability to identify Alzheimer’s.
In a small trial, patients given an existing drug showed no cognitive decline over three years.
Scientists can predict who will live past 100 using a subset of 150 genetic variations.
An epidemic of age-related dementia looms
A compound that attacks amyloid plaques fails to help patients, raising questions about similar therapeutics.
Research uncovers the cellular defects that cause this type of forgetfulness.
People with rare, inherited forms of the neurological disease have early markers—which researchers can use to test preventive treatments.
The discovery could one day allow doctors to catch the disease before it’s done irreversible damage.